“…So far, in vivo active riboswitches rely on a small set of ligands – theophylline, tetracycline, neomycin [53], 2,4‐dinitrotoluene [107], ammeline, 5‐aza‐cytosine [108] or pyrimido[4,5‐ d ]pyrimidine‐2,4‐diamine (PPDA) [43], although several dozen small molecule‐binding aptamers have been selected by a process called SELEX (systematic evolution of ligands by exponential enrichment), an in vitro technology invented about a decade before the discovery of natural riboswitches [109, 110]. During SELEX, a huge combinatorial library of RNA (and sometimes DNA) molecules is subjected to affinity of a small RNA chromatography to the ligand of choice.…”